DNASENSE ApS: Financial statements 2016
CVR: 36036869
Source: annual report 2016, Danish Business Authority
01/10/2015 – 30/09/2016
DNASENSE ApS (CVR 36036869) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,123,634 and a net result of DKK 359,058. Equity in the 2016 report amounted to DKK 512,696. The solvency ratio was 58.4%.
- Gross Profit
- DKK 1,123,634
- Profit/Loss
- DKK 359,058
- Equity
- DKK 512,696
- Total Assets
- DKK 877,412
Find more companies like DNASENSE ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout DNASENSE ApS
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.